Tofacitinib XR
NDC 70377-057, Tofacitinib, tablet, film coated, extended release, from Biocon Pharma Inc.
- Product NDC
- 70377-057
- Status
- Listed
- Labeler
- Biocon Pharma Inc
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA219442
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70377-057 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOFACITINIB CITRATE11 mg/1
Pharmacologic classes
Janus Kinase Inhibitor [EPC]; Janus Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70377-057-11 | 70377005711 | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (70377-057-11) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/f0160e3d-63ea-75fb-4b88-fe3d6a6ce030NADAC price for package 70377005711
GET /v1/drugs/nadac/70377005711
Use it
Look up 70377-057 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70377-057 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70377-057. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.